Tirz Rx / Evidence
Evidence
Tirzepatide: animal studies vs human trial evidence
Rodent thyroid tumors vs SURPASS and SURMOUNT human data: what tirzepatide's animal studies actually showed, and why the FDA still approved it.
Tirzepatide before and after claims: what the trials actually show
Before and after photos aren't data. Here's what SURMOUNT and SURPASS actually recorded on tirzepatide weight loss and A1C over 36 to 72 weeks.
Tirzepatide clinical trials: what SURMOUNT and SURPASS show
SURMOUNT-1 showed up to 22.5% weight loss at 72 weeks; SURPASS trials cut A1C by up to 2.4 points. Here's what the tirzepatide trial data actually says.
Tirzepatide human studies: what the trials actually show
SURPASS and SURMOUNT enrolled over 15,000 people. Here's what the tirzepatide human studies found on weight loss, A1c, and side effects, trial by trial.
Tirzepatide mechanism of action: how the drug actually works
Tirzepatide activates GLP-1 and GIP receptors together. Here's the receptor biology, trial data (SURMOUNT, SURPASS), and what it means for side effects and dosing.
Tirzepatide results: what the trial evidence shows
SURMOUNT and SURPASS trial data on tirzepatide: up to 22.5% weight loss and A1C drops of 2.1 points. See the real numbers, timelines, and risks.